Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study

Author
R. Pradhan
O. H. Y. Yu
R. Platt
L. Azoulay
Keywords
Humans
*Diabetes Mellitus, Type 2/drug therapy/epidemiology/complications
*Dipeptidyl-Peptidase IV Inhibitors/adverse effects
Cohort Studies
Sulfonylurea Compounds/adverse effects
*Skin Neoplasms/chemically induced/epidemiology/complications
*Melanoma/epidemiology/complications
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Dipeptidyl Peptidase 4
Drug Effects
Medical Oncology
pharmacoepidemiology
Year of Publication
2023
Journal
BMJ Open Diabetes Res Care
Volume
11
ISBN Number
2052-4897
Accession Number
37949470
DOI
10.1136/bmjdrc-2023-003550